ClinicalTrials.govpublic full text
Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients
metastatic castration-resistant prostate cancer, mtor inhibitor mln0128, psa, 13-143, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 898282
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.